Further research on the link between FOXM1 and IAPs, which are intimately related to anti-cancer therapy resistance [276], may reveal additional FOXM1 transcriptional targets linked to ovarian cancer chemoresistance. Here, FOXM1 is linked to ovarian carcinoma.